Qure.ai's AI-Driven Chest X-ray Solution Receives FDA Clearance for Enhanced Lung Nodule Detection - News Summed Up

Qure.ai's AI-Driven Chest X-ray Solution Receives FDA Clearance for Enhanced Lung Nodule Detection


Having already effectively deployed and implemented this solution globally, this clearance marks yet another ground-breaking leap in our pioneering efforts to combat lung cancer. The qXR-LN algorithm demonstrated a statistically significant and clinically meaningful enhancement in pulmonary nodule detection across all reader groups. As per the American Cancer Society, lung cancer is by far the leading cause of cancer-related deaths in the US, accounting for about 1 in 5 of all cancer deaths[i]. Worldwide, 15–20 percent of males with lung cancer are non-smokers, whereas over 50 percent of women with lung cancer are non-smokers[iii]. Lung nodule detection on plain film is crucial for the early identification of malignancy risk, enabling timely interventions and improving patient outcomes.


Source: Forbes January 08, 2024 20:16 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */